Recall of Dimension® Creatinine (CRE2) Due to Potential Imprecision
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Health Canada has issued a recall for Dimension® Creatinine (CRE2) products due to potential imprecision in quality control and patient sample results for specific lots.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on April 2, 2026 and geographically references Canada. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, health-product.
Recall Alert: Dimension® Creatinine (CRE2)
What Happened
Siemens Healthineers has confirmed through investigation of customer complaints a potential for imprecision in Dimension® Creatinine (CRE2) quality control and patient sample results when using specific lot numbers on the Dimension system.
Which Products Are Affected
The affected products are Dimension® Creatinine (CRE2) with the following details:
- Lot numbers: GA6307 and BA7005
- Model or catalogue number: 10872079 No specific quantities, UPCs, or date ranges were provided in the recall notice. The recall is issued by Health Canada and involves products from Siemens Healthcare Diagnostics Inc., located in Newark, Delaware, United States.
What You Should Do
The recall notice does not specify explicit action steps. Affected users should refer to the official recall source for further instructions.
Why This Matters
This recall highlights potential risks in medical diagnostic accuracy, which could affect patient results and necessitate corrective measures to ensure reliable healthcare testing.
Source
This information is from Health Canada. For full details, visit: https://recalls-rappels.canada.ca/en/alert-recall/dimensionr-creatinine-cre2
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,315 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 2, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.